전체 프로그램

ADC 882 · Antibody 4071 · CGT 2714 · 자동 수집 갱신 권장 · 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved173 programs

데이터 갱신 주기입니다. 갱신 대기 7,666개 보기 · Curated Core는 주간 자동 동기화됩니다.

CGTLimited DatastaleZhejiang Provincial People's Ho…Phase 1

CB CAR-NK18.2 (CB CAR-NK18.2)

Gastric Cancer; Pancreas Adenocarcinoma · Gastric Cancer

#GastricCancer#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Active
CGTLimited DatastaleSecond Affiliated Hospital, Sch…Phase 1

CB dualCAR-NK19/70 (CB dualCAR-NK19/70)

B-cell Non Hodgkin Lymphoma · B-cell Non Hodgkin Lymphoma

#B-cellNonHodgkinLymphoma#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 1Status Active
CGTLimited DatastaleBeijing JD Biotech Co. LTD.Phase 1

CD123-CAR-NK cells (CD123-CAR-NK cells)

Acute Myeloid Leukemia Refractory; Acute Myeloid Leukemia Recurrent · FRα

#FR#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Active
CGTLimited DatastaleBeijing JD Biotech Co. LTD.Phase 1

CD19-CAR-NK (CD19-CAR-NK)

Adult Relapsed/Refractory B-cell Hematologic Malignancies · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Active
CGTLimited DatastaleSecond Affiliated Hospital, Sch…Phase 1

CD19-CAR-NK/T (CD19-CAR-NK/T)

Primary Mediastinal B-cell Lymphoma (PMBCL); Mantle Cell Lymphoma (MCL) · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleBaylor College of MedicinePhase 1

CD19.CAR-aNKT cells (CD19.CAR-aNKT cells)

Refractory B-Cell Non-Hodgkin Lymphoma; Refractory B-Cell Small Lymphocytic Lymphoma · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleChanghai HospitalPhase 1

CD19/BCMA CAR NK (CD19/BCMA CAR NK)

IgG4 Related Disease · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleHangzhou Qihan Biotech Co., Ltd.Phase 1

CD33/CLL1 dual CAR-NK cell (CD33/CLL1 dual CAR-NK cell)

AML, Adult; Minimal Residual Disease · CD33

#CD33#CGT#Phase1#cell-gene-therapy#CAR-T+5
Trials 1Status Active
CGTLimited DatastaleNational Institute of Allergy a…Phase 2

CD34+ HSCs transduced with the lentivirus vector, VSV-G pseudotyped CL20-4i-EF1α-hγc-OPT (CD34+ HSCs transduced with the lentivirus vector, VSV-G pseudotyped CL20-4i-EF1α-hγc-OPT)

X-Linked Combined Immunodeficiency Diseases · CD3

#CD3#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 1Status Active
CGTLimited DatastaleFundacion Clinic per a la Recer…Phase 1

CD5CAR-CBNK (CD5CAR-CBNK)

Fungal Infection · Fungal Infection

#FungalInfection#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 1Status Recruiting
CGTLimited DatastalePersonGen BioTherapeutics (Suzh…Phase 1

CD7 CAR-T cells infusion (CD7 CAR-T cells infusion)

T-lymphoblastic Lymphoma; NK/T Cell Lymphoma · T-lymphoblastic Lymphoma

#T-lymphoblasticLymphoma#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Active
CGTLimited DatastaleSecond Affiliated Hospital, Sch…Phase 1

CD70 CAR-NK (CD70 CAR-NK)

Relapsed/Refractory T-cell Lymphoma; Relapsed/Refractory Acute Myeloid Leukemia · FRα

#FR#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleM.D. Anderson Cancer CenterPhase 2

CD70.CAR NK Cells (CD70.CAR NK Cells)

Large B-cell Lymphoma; Hodgkin Lymphoma · Large B-cell Lymphoma

#LargeB-cellLymphoma#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleHangzhou Suxi Biopharmaceutical…Phase 2

Chidamide Combined with NKG2D CAR-NK Cell Therapy (Chidamide Combined with NKG2D CAR-NK Cell Therapy)

HIV (Human Immunodeficiency Virus) · HIV (Human Immunodeficiency Virus)

#HIVHumanImmunodeficiencyVirus#CGT#Phase2#cell-gene-therapy#CAR-T+2
Trials 1Status Recruiting
CGTLimited DatastaleSecond Affiliated Hospital of G…Phase 1

Claudin6, GPC3, Mesothelin, or AXL targeting CAR-NK cells (Claudin6, GPC3, Mesothelin, or AXL targeting CAR-NK cells)

Stage IV Ovarian Cancer; Testis Cancer, Refractory · FRα

#FR#CGT#Phase1#cell-gene-therapy#CAR-T+5
Trials 1Status Recruiting
CGTLimited DatastaleWashington University School of…Phase 2

Cytokine-induced memory-like NK cells (Cytokine-induced memory-like NK cells)

Refractory Acute Myeloid Leukemia; Relapsed Acute Myeloid Leukemia · FRα

#FR#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 1Status Discontinued
CGTLimited DatastaleEssen BiotechPhase 2

Dual-Target Antigen-Selected CAR-NK (Dual-Target Antigen-Selected CAR-NK)

Cancer; Breast Cancer · MET

#MET#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleBeijing BiotechPhase 2

EB-DT-CAR-NK (Dual-target CAR-NK cells, Dual-target CAR-NK cells (EB-DT-CAR-NK))

Breast Cancer (Locally Advanced or Metastatic); HER2-positive Breast Cancer · HER2

#HER2#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleBeijing BiotechPhase 2

EB-CAR30-NK (EB-CAR30-NK)

B2 Thymoma; Thymic Carcinoma · B2 Thymoma

#B2Thymoma#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleBeijing BiotechPhase 2

EB-CAR5-NK (EB-CAR5-NK)

B2 Thymoma; Thymic Carcinoma · B2 Thymoma

#B2Thymoma#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting

5 / 9 pages

← PreviousNext →